✦ LIBER ✦
Addition of the neurokinin 1 receptor antagonist aprepitant to standard antiemetic therapy improves control of chemotherapy-induced nausea and vomiting : Results from a randomized, double-blind, placebo-controlled trial in Latin America
✍ Scribed by Sergio Poli-Bigelli; Jose Rodrigues-Pereira; Alexandra D. Carides; Guoguang Julie Ma; Krista Eldridge; Anita Hipple; Judith K. Evans; Kevin J. Horgan; Francesca Lawson; On behalf of the Aprepitant Protocol 054 Study Group
- Publisher
- John Wiley and Sons
- Year
- 2003
- Tongue
- English
- Weight
- 114 KB
- Volume
- 97
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.